Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
3,203,885
-
Total 13F shares
-
2,497,435
-
Share change
-
+14,844
-
Total reported value
-
$203,092,527
-
Price per share
-
$81.40
-
Number of holders
-
78
-
Value change
-
+$2,126,789
-
Number of buys
-
42
-
Number of sells
-
27
Institutional Holders of UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) as of Q4 2017
As of 31 Dec 2017,
UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) was held by
78 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,497,435 shares.
The largest 10 holders included
FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, Vanguard Group Inc, BlackRock Inc., STATE STREET CORP, WCM INVESTMENT MANAGEMENT/CA, Russell Investments Group, Ltd., and Ancora Advisors, LLC.
This page lists
78
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.